People with diabetes who use GLP-1 medications primarily for glucose control face different switching considerations than those using these medications solely for weight loss
the SURPASS-3 MRI substudy and the SELECT adiposity analysis, both in Lancet titles
Some healthcare providers may consider prescribing both medications simultaneously in select cases, particularly when patients have not achieved adequate weight loss with semaglutide alone or when attempting to transition from one medication to another
The primary reasons include gastrointestinal side effects such as nausea, cost, and the hassle of self-injection
The reliability of research chemicals semaglutide is directly tied to their initial purity and subsequent handling
These include hormone replacement therapy, in-home or in-person hypnotherapy, and making alterations to your lifestyle.